Posts Tagged: coronavirus
New Year, New Models: How the Pandemic May Forever Change Practice at the USPTO
Last year brought unprecedented changes as to how the United States Patent and Trademark Office (USPTO) conducts business. Prior to the pandemic, the USPTO was already a …
How the 2020 Coronavirus Pandemic Changed IP Practice
Greek philosopher Heraclitus is credited with saying “the only thing that is constant is change.” In 2020, life for everyone changed, including for those in the intellectual property (…
Brazilian Ministry of Health Accelerates Examination of Pharma Patent Applications
The Brazilian Patent and Trademark Office (BPTO) presently offers more than 15 programs to speed up examination of patent applications. The prioritization of certain patent applications by means …
Panelists Urge Americans to Trust IP, Trust Vaccines, Listen to Science in COVID-19 Debate
IPWatchdog’s most recent webinar focused on the role of IP in the development of the most promising vaccines to combat COVID-19 and included speakers from the …
IPW Webinar – The Race for a Coronavirus Vaccine: The Intersection of Science & IP Policy
Join Gene Quinn, patent attorney and leading commentator on patent law and innovation policy, on Tuesday, September 22 at 1pm ET. Gene will host a wide-ranging conversation on …
A Changing Economy Provides an Opportunity to Reassess Corporate IP Strategy
The current novel coronavirus pandemic and the resulting economic fallout may provide a good opportunity to step back and reevaluate the way companies approach intellectual property. Many …
Business (Almost) as Usual at Brazilian IP Courts and IPO
Like most countries, Brazil has been facing severe restrictions in an attempt to slow down the spread of COVID-19. Non-essential services are currently closed in almost all …
International Approaches to Accelerating Innovation and Access in the Pandemic
In the wake of COVID-19, government officials around the world face unprecedented decisions about when and to what extent they should reopen their respective societies before effective …
Practice at the Patent Trial and Appeal Board During a Pandemic
The business of the Patent Trial and Appeal Board (PTAB) continues on as most practitioners transition into another month of working from home. Like many courts, the …
Conservative Leaders Rebut Proposed Denial of Exclusivity on COVID Meds
More than 30 leading conservative and libertarian organizations have joined on a letter to Congress, voicing “strong opposition” to principles, recently unveiled by four senior lawmakers, that would …
Stand Up to the Anti-Patent COVID-19 Narrative
It may seem odd, as unprecedented public/private sector R&D alliances work to discover and develop therapies to counter COVID-19, that some are trying to punish …
Examining Antitrust Guidance on Cooperation in Fighting COVID-19
The novel coronavirus pandemic has upended our lives, creating a far-from-normal “new normal.” And it has also given rise to countless collaborations between and among universities, hospitals, …
Don’t Let Life Sciences Innovation Become Another Coronavirus Casualty
With two-thirds of the world in lockdown and no clear way out of the novel coronavirus crisis, it’s increasingly obvious that biopharmaceutical innovation will play a …
3M Targets N95 Respirator Company’s Alleged Price-Gouging Scheme via Trademark Infringement Suit
On April 10, multinational corporation 3M filed a lawsuit alleging trademark infringement claims against N95 respirator distributor Performance Supply, LLC, in the Southern District of New York. Central …
Facilitating Innovation to Fight Coronavirus Act— Legislation That’s a Mixed Bag
Draft legislation has emerged that ostensibly would boost rapid innovation to combat the coronavirus. Bottom line: The bill is a mixed bag with a lot of questions... …
